Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia. - Wikidata - wikimedia - TriplyDB

Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.

Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.

http://www.wikidata.org/entity/Q33399398

about

Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.CD16+ monocytes control T-cell subset development in immune thrombocytopenia.Polymorphisms of the IL-23R gene are associated with primary immune thrombocytopenia but not with the clinical outcome of pulsed high-dose dexamethasone therapy.Immune dysregulation in immune thrombocytopenia.Cellular immune dysfunction in immune thrombocytopenia (ITP).Advances in immunopathogenesis of adult immune thrombocytopenia.Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia.Elevated levels of T-cell immune response cDNA 7 in patients with immune thrombocytopenia.Elevated expression of NLRP3 in patients with immune thrombocytopenia.Mesenchymal Stem Cells Immunosuppressed IL-22 in Patients with Immune Thrombocytopenia via Soluble Cellular Factors.Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia Imbalanced immune homeostasis in immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Th22 and related cytokines in inflammatory and autoimmune diseases.A gradient of glucocorticoid sensitivity among helper T cell cytokines.Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia.Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia.Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia.

P2860

Q33401624-F4C3DFBB-C401-441D-9D55-872E07F9FA4B Q33402944-9193F69E-7499-4F6D-A716-7199B545CB4E Q33406925-745E53F9-EEEF-4809-A87A-DEA58883F02E Q33407649-B4E13633-07FD-41E7-BC46-18700CBA42E9 Q33409710-A9B67AF3-6ED8-4782-814C-72B2CEF10E68 Q33411672-CE41D432-376A-4FDB-A05D-B0536601DB90 Q33412177-B794D9D9-2E5C-4A33-ABBB-8370C900DEC4 Q33413850-AFE6B622-50D6-4CD9-AB65-CF77B6DCD3FE Q33425432-AEC4EE6F-CF33-4B0D-83DF-0CB3F4A432C6 Q33427075-745F8990-5F58-4BA7-818C-BAD777370F0E Q33430065-F7FF0958-C0BC-41C0-B3FD-79111D32348E Q33433145-5D76580C-1A97-4523-9EFE-7C63F5873173 Q33439412-05CA23EA-097E-4E0E-AF17-34037D03238F Q38068964-E3F29006-D62E-4E61-9387-B1B67DC7354A Q41639471-18E0CC3E-8FD4-4ACC-A506-A17ADFA61F05 Q41922047-F1CBF18D-6A62-48FE-AEA5-85BAE21D8E8C Q48256029-4F9DA8C3-0FC8-4D0D-9DE9-17499EF75058 Q49293079-00F1E16E-0FBB-447B-A71F-694CD537F919 Q52695218-09580BA6-9C27-43D3-9786-0956AAFCE09F

P2860

Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.

http://www.wikidata.org/entity/Q33399398

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@ast

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@en

type

label

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@ast

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@en

prefLabel

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@ast

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@en

P1433

Q33399398-2D7C68F7-0B6B-4C37-8BD9-B2DF220DFE0D

P1476

Q33399398-A1AD5C68-B84B-4194-96EA-E34CB1C29CA0

P2093

Q33399398-0913BEFC-8E27-4F51-ABD6-58C5F8F185F9

Q33399398-15FEE91B-2FCA-4C2B-955B-FFAB2B1C90CC

Q33399398-38F52C5B-9D16-4DCC-9C18-8B9EA0168082

Q33399398-478A02B8-70D6-4D21-B567-B67C5A2666EA

Q33399398-6723E374-39F9-43CE-99D5-9595B67990B0

Q33399398-77EC5554-6629-470D-B8E9-5708806AF78E

Q33399398-9EA89B5B-C655-41DB-910F-49A5537D844F

Q33399398-ACEB42DF-001F-4739-9639-57BAB24A518E

Q33399398-B3C8FECD-4E5C-4BFD-A810-0B33EC77329E

Q33399398-E0585AB3-C500-4678-81DF-E3C8BA5AA555

P2860

Q33399398-0C4BC0CF-845A-4F6D-82D8-57B3B569E9D8

Q33399398-116E7D42-4A44-47D2-B075-C3E81B42B17B

Q33399398-131A73AB-9284-4E8A-8D8C-3DCF5350E5D4

Q33399398-2C51A9E4-2F33-4A91-A5D2-EC7610ABE217

Q33399398-2F87B72A-47F7-4DC5-B82D-ABE45538D689

Q33399398-35A1439C-D2A4-421E-B09A-11A069165B92

Q33399398-51E60AD5-3E9B-4884-935A-CBE627220535

Q33399398-722F381A-FC10-4E48-985E-29B2ED660E8D

Q33399398-750F01A7-A3C5-48A5-ABFE-43D5210420EF

Q33399398-7A129701-529E-48E4-A5E6-25C8CA8AD87A

P2888

Q33399398-B7D6C7CB-D161-4360-9B99-39E8900E2673

P304

Q33399398-51253F57-A888-4F0D-9A96-533E70B9173A

P31

Q33399398-09880ACE-0BEA-4CD3-A988-E82C60D2851D

P356

Q33399398-04798518-75E6-4735-BF39-A07590B5B2CF

P433

Q33399398-36402475-6F0E-41BE-8282-452B05EE3C39

P478

Q33399398-DAA4F2D0-05FF-4CF7-83AB-241BE49189C8

P577

Q33399398-4A7C979A-E719-4C8A-B4AB-923BA6C91420

P6179

Q33399398-9BB02302-C8C9-4757-A839-639675F9D26D

P698

Q33399398-5FCD685D-B5BC-4079-8244-633001992AE1

P921

Q33399398-20F732EA-FE8D-42B6-B202-ADB555DCBB41

Q33399398-AC1E7986-AB41-4CF7-8EEF-C528ACE9EC08

P356

S10875-012-9649-4

P1433

Journal of Clinical Immunology

P1476

Effects of high-dose dexametha ...... on in immune thrombocytopenia.

@en

P2093

Chen Wei

http://www.w3.org/2001/XMLSchema#string

Cheng Hai

http://www.w3.org/2001/XMLSchema#string

Chong Chen

http://www.w3.org/2001/XMLSchema#string

Jiang Cao

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

Li Zhen-yu

http://www.w3.org/2001/XMLSchema#string

Wei Sang

http://www.w3.org/2001/XMLSchema#string

Xu Kai-lin

http://www.w3.org/2001/XMLSchema#string

Yan Zhi-ling

http://www.w3.org/2001/XMLSchema#string

Zeng Ling-yu

http://www.w3.org/2001/XMLSchema#string

P2860

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

International consensus report on the investigation and management of primary immune thrombocytopenia

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

Decreased serum IL-22 levels in patients with systemic lupus erythematosus

Biology of interleukin-22.

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.

P2888

s10875-012-9649-4

P304

523-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-012-9649-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1025171846

http://www.w3.org/2001/XMLSchema#string

P698

22289995

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia